ID   MAb-G2
AC   CVCL_A6KF
SY   G2
DR   Wikidata; Q107115918
RX   DOI=10.1007/978-94-011-2044-9_84;
RX   PubMed=1572415;
RX   PubMed=2091939;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
OX   NCBI_TaxID=9606; ! Homo sapiens
OX   NCBI_TaxID=10090; ! Mus musculus
HI   CVCL_3419 ! SHM-D33
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 23-09-21; Version: 2
//
RX   DOI=10.1007/978-94-011-2044-9_84;
RA   Matsuda M., Kamei M., Sugimoto N., Hashizume S.;
RT   "Application of anti-tetanus human monoclonal antibodies.";
RL   (In) Animal cell technology. Basic and applied aspects, Vol. 5; Kaminogawa S., Ametani A., Hachimura S. (eds.); pp.617-623; Springer; Dordrecht (1993).
//
RX   PubMed=1572415; DOI=10.1007/BF02427384;
RA   Matsuda M., Kamei M., Sugimoto N., Ma Y., Hashizume S.;
RT   "Characteristics of toxin-neutralization by anti-tetanus human
RT   monoclonal antibodies directed against the three functional domains
RT   [A], [B] and [C] of the tetanus toxin molecule and a reliable method
RT   for evaluating the protective effects of monoclonal antibodies.";
RL   Eur. J. Epidemiol. 8:1-8(1992).
//
RX   PubMed=2091939; DOI=10.1007/BF00151713;
RA   Kamei M., Hashizume S., Sugimoto N., Ozutsumi K., Matsuda M.;
RT   "Establishment of stable mouse/human-human hybrid cell lines producing
RT   large amounts of anti-tetanus human monoclonal antibodies with high
RT   neutralizing activity.";
RL   Eur. J. Epidemiol. 6:386-397(1990).
//